I’ve been reflecting on a particular patient case that has significantly influenced not just my practice as an IVF specialist, but also my approach to investing. It was during a routine follow-up with a couple whose IVF cycle had unfortunately failed. The embryo transfer had appeared promising, yet it did not result in a pregnancy. In such moments, as a doctor, you find yourself navigating the delicate balance between conveying clinical realities and offering emotional solace. I was reminded of how unpredictable both life and business can be.
In the world of IVF, as in investing, failure is an inevitable part of the journey. It’s easy to forget that every failed cycle, much like a failed investment, carries with it an opportunity for learning and growth. For this couple, the outcome was devastating. But in our discussions that followed, I realized they were not defeated; they were determined to understand the ‘why’ behind the failure. It struck me how their resilience and quest for clarity mirrored the journey of many founders I’ve backed.
The lesson here was profound: failure isn’t just a setback; it’s a chance to refine strategies and improve future outcomes. This realization has become a cornerstone of my investment philosophy. Just as each IVF cycle is meticulously reviewed to identify potential improvements, I began applying the same rigorous analysis to my investment decisions.
There is a common thread between the two: both require a deep understanding of complex systems, whether biological or financial, and both demand an acceptance of inherent uncertainties. In IVF, even when all parameters appear ideal, the outcome can still be unpredictable due to the complex interplay of biological factors. Similarly, in investing, even the most promising startups can falter due to unforeseen market dynamics or operational challenges.
One fundamental shift in my investment approach came from understanding the importance of reviewing failures with a constructive lens. After every unsuccessful IVF cycle, my team and I meticulously analyze the data: how the ovaries responded to stimulation, the quality of retrieved eggs, the progression of embryos, and the timing of the transfer. This detailed review helps us identify what is known, what remains uncertain, and what can be optimized for the future. The same principle can be applied to investments—analyzing what went wrong, understanding market conditions, and identifying areas for improvement.
Moreover, I’ve learned to appreciate the value of emotional resilience and support systems. Just as patients benefit from therapy or coaching during challenging IVF journeys, founders too need mentorship and a supportive network to navigate the ups and downs of building a company. The emotional toll of a failed IVF cycle is not unlike the stress experienced by entrepreneurs facing setbacks. Both scenarios underscore the need for mental fortitude and the ability to pivot strategies when necessary.
In the case of IVF, the science is continually evolving, offering new techniques and protocols that improve success rates. Similarly, the startup ecosystem is dynamic, with new technologies and business models emerging rapidly. As an investor, staying informed and adaptable is crucial. The lesson from the failed IVF cycle taught me to remain open to new ideas and approaches, whether in the lab or the boardroom.
What remains constant, however, is the need for transparency and honesty both in medicine and investing. Patients deserve clear, specific explanations and realistic hope, just as founders deserve candid feedback and strategic guidance. This transparency fosters trust and lays the groundwork for future successes.
Reflecting on this experience, I’ve come to value the lessons from both domains more deeply. Each failed IVF cycle and each investment that doesn’t pan out enriches my understanding and sharpens my strategies. It’s a reminder that failure, while painful, is not the end but a necessary step toward eventual success.
In both fields, the ultimate goal is to create life—whether through the birth of a child or the growth of a company. And while the paths are fraught with challenges, they are also filled with moments of profound learning and unexpected joy. As I continue this journey, I’m grateful for the lessons that failure teaches and the resilience it builds, both in myself and in those I have the privilege to support.
In the end, it’s not about eliminating failure but embracing it as a catalyst for growth and innovation. This is the unexpected lesson from a failed IVF cycle that transformed my investment approach, and it’s a philosophy I carry with me in every endeavor.